Stay updated on Tralokinumab Combo in Japanese AD: Clinical Trial
Sign up to get notified when there's something new on the Tralokinumab Combo in Japanese AD: Clinical Trial page.

Latest updates to the Tralokinumab Combo in Japanese AD: Clinical Trial page
- Check4 days agoChange DetectedThe page’s display revision identifier was updated from v3.5.2 to v3.5.3.SummaryDifference0.0%

- Check11 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check39 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0 on the page.SummaryDifference0.0%

- Check47 days agoChange DetectedSite revision updated to v3.4.3, replacing the previous v3.4.2 tag.SummaryDifference0.0%

- Check76 days agoChange DetectedRevision: v3.4.2 was added and the funding-lapse notice about NIH operations was removed. These are maintenance-related updates that do not affect core study content, endpoints, or results; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check83 days agoChange DetectedAdded a government funding/status notice and a page revision tag (Revision: v3.4.1). Removed publications that were automatically filled from PubMed.SummaryDifference0.6%

Stay in the know with updates to Tralokinumab Combo in Japanese AD: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tralokinumab Combo in Japanese AD: Clinical Trial page.